Author: Amanda Moore
-
Short answer: Bowel obstruction after HIPEC is a recognized complication of cytoreductive surgery and heated intraperitoneal chemotherapy. Studies have documented hospital readmissions for small bowel obstruction months and even years after surgery. What those studies may miss are the episodes patients manage entirely at home, without an emergency department visit or an admission. This started…
-
A wild type appendix cancer result means the test did not detect a mutation in the genes it was set up to examine. It does not mean your tumor has no mutations, and it does not mean the drugs built for wild type colon cancer will work for you. My husband David had his appendix…
-
Christine Hill has lived with signet ring cell appendix cancer since 2021. This is her story of six surgeries, two ostomy bags, a tumor whose molecular profile changed over time, and a decision she makes every single day to keep living. Christine and I met early in my appendix cancer journey, during a Saturday PMP…
-
A 71-year-old man with stage IV appendiceal mucinous adenocarcinoma remained recurrence-free for ten years, even though he never had HIPEC. His case is a reminder that survival is shaped by more than stage alone. Tumor biology, treatment decisions, and response to therapy all matter. I read a lot of case reports. Most of them I…
-
The appendix cancer registry exists because this disease is too rare for any single hospital, or any single country, to study on its own. Pooling patient information across borders is the only way to build a group large enough for researchers to find patterns, design trials, and change how appendix cancer is treated. Last week…
-
A new pathology study found a treatment target, a protein called Claudin 18.2, on some high-grade appendiceal mucinous carcinoma tissue. That same protein is the target of an FDA-approved drug for certain stomach and gastroesophageal cancers. This does not mean that drug works for appendix cancer. It means there is now a reason to look.…